NMDA receptor antagonists for neuroprotection

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9079852
APP PUB NO 20140031363A1
SERIAL NO

13862647

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are compounds, pharmaceutical compositions and methods of treatment or prophylaxis of disorders associated with NMDA receptor activity, including neuropathic pain, stroke, traumatic brain injury, epilepsy, and related neurologic events or neurodegeneration. Compounds are of the general Formula I, or a pharmaceutically acceptable salt, ester, prodrug or derivative thereof are provided:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EMORY UNIVERSITYATLANTA GA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dingledine, Raymond J Atlanta, US 8 35
Liotta, Dennis C Atlanta, US 145 2450
Mosley, Cara Atlanta, US 3 10
Myers, Scott Atlanta, US 75 1732
Snyder, James P Atlanta, US 36 313
Tahirovic, Yesim Altas Decatur, US 6 29
Traynelis, Stephen F Decatur, US 22 98
Wilson, Lawrence Atlanta, US 15 182

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 14, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00